End-of-day quote
Korea S.E.
06:00:00 2024-04-29 pm EDT
5-day change
1st Jan Change
1,206
KRW
+1.26%
+3.61%
-27.91%
T Scientific Co.,Ltd announced that it expects to receive KRW 10 billion in funding from Swanicoco Co., Ltd. and other investors
T Scientific Co.,Ltd (KOSDAQ:A057680) announced a private placement of series 14 non-guaranteed private equity non-separable bond with underwriting rights for gross proceeds of KRW 10,000,000,000 on January 4, 2021. The transaction will include participation from Swanicoco Co., Ltd. for KRW 9,000,000,000, Jinwon Kang for KRW 500,000,000 and Seo Yoon-seong for KRW 500,000,000. The bonds will not bear any coupon rate, bear yield to maturity of 0% and will mature on January 12, 2024. The bonds are 100% convertible into 2,904,443 common shares at a conversion price of KRW 3,443 from January 12, 2022 to December 11, 2023. The shares have a hold period of one year. The company will raise funding through third party allotment. The transaction is expected to close on January 12, 2021. The transaction has been approved by the board of directors of the company.
T Scientific Co.,Ltd. announced that it has received KRW 2.99999997 billion in funding from WIZIT Co., Ltd.
Apr. 24
CI
T Scientific Co.,Ltd. announced that it expects to receive KRW 2.99999997 billion in funding from WIZIT Co., Ltd.
Apr. 16
CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.
Mar. 27
CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. for KRW21.7 billion.
Feb. 15
CI
T Scientific Co.,Ltd. announced that it has received KRW 5 billion in funding from FSN Co., Ltd.
Jan. 22
CI
T Scientific Co.,Ltd. announced that it expects to receive KRW 5 billion in funding from FSN Co., Ltd.
Jan. 21
CI
FSN Co., Ltd. announced that it has received KRW 10 billion in funding from T Scientific Co.,Ltd.
Jan. 18
CI
FSN Co., Ltd. announced that it expects to receive KRW 10 billion in funding from T Scientific Co.,Ltd. and other investors
Jan. 11
CI
T Scientific Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-21
CI
T Scientific Co.,Ltd signed a contract to acquire It Nomads Co., Ltd from Kim Seongjin and others for KRW 21 billion.
22-12-15
CI
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd
22-12-13
CI
T Scientific Co.,Ltd announced that it has received KRW 16 billion in funding from Daiduck Piping Co., Ltd.
22-09-29
CI
T Scientific Co.,Ltd(KOSDAQ:A057680) added to S&P Global BMI Index
22-09-19
CI
T Scientific Co.,Ltd announced that it has received KRW 4.99999914 billion in funding from WIZIT Co., Ltd.
22-08-04
CI
T Scientific Co.,Ltd announced that it expects to receive KRW 20 billion in funding from Daiduck Piping Co., Ltd. and another investor
22-07-28
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4.9999995 billion in funding from T Scientific Co.,Ltd
22-06-21
CI
T Scientific Co.,Ltd announced that it expects to receive KRW 4.99999914 billion in funding from WIZIT Co., Ltd.
22-06-20
CI
T Scientific Co.,Ltd agreed to acquire 60.4% interest in Plutos DS Co., Ltd from Eljovis Smart Trade Co., Ltd. and others for KRW 24.15 billion.
22-04-10
CI
T Scientific Co.,Ltd and Oji-Q Co., Ltd. completed the acquisition of Bithumb Korea Co., Ltd. from OGQ Corp. for approximately KRW 35,999 million.
22-03-22
CI
T Scientific Co.,Ltd announced that it has received KRW 30 billion in funding
22-02-02
CI
T Scientific Co.,Ltd announced that it expects to receive KRW 30 billion in funding
21-11-24
CI
T Scientific Co., Ltd. announced that it has received KRW 5 billion in funding from His-Story Investment Co.,Ltd. and other investors
21-03-18
CI
T Scientific Co., Ltd. announced that it expects to receive KRW 5 billion in funding from His-Story Investment Co.,Ltd. and other investors
21-03-09
CI
Brain Contents CO., LTD. announced that it has received KRW 39.5 billion in funding from WIZIT Co., Ltd., Eyesvision Corp., T Scientific Co., Ltd., Powernet Technologies Corporation, JSI Company Co., Ltd., and another investor
21-02-07
CI
Medifron DBT Co., Ltd. announced that it has received KRW 14.99999874 billion in funding from T Scientific Co., Ltd.
21-02-04
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
T Scientific Co Ltd, formerly Omnitel Inc, is a Korea-based company mainly engaged in the provision of mobile coupons. The Company mainly sells mobile gift certificates and provides mobile commerce solution services.
More about the company
1st Jan change
Capi.
-27.91% 59.7M -14.95% 189B +0.72% 166B +0.69% 152B +7.21% 99.37B +5.88% 77.36B +13.45% 70.76B -7.93% 70.46B -22.07% 51.83B -6.79% 44.34B
Other IT Services & Consulting
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1